XML 167 R150.htm IDEA: XBRL DOCUMENT v3.21.1
ADDITIONAL INFORMATION-CONDENSED FINANCIAL STATEMENTS OF THE PARENT COMPANY (Condensed Cash Flows) (Details)
12 Months Ended
Dec. 31, 2020
CNY (¥)
Dec. 31, 2020
USD ($)
Dec. 31, 2019
CNY (¥)
Dec. 31, 2018
CNY (¥)
Dec. 31, 2020
USD ($)
Cash flows from operating activities:          
Net income ¥ 335,255,274 $ 51,380,119 ¥ 924,352,495 ¥ 405,575,533  
Adjustments to reconcile net income to net cash provided by (used in) operating activities:          
Issuance cost paid for issuance of convertible senior notes 0 0 18,646,101 0  
Share of income from subsidiaries 52,705,838 8,077,523 48,854,715 (2,609,853)  
Exchange (gain)/loss 336,522,915 51,574,393 (8,808,559) (33,681,095)  
Changes in operating assets and liabilities:          
(Increase)/decrease in other current assets (1,112,028,646) (170,425,846) 57,559,179 (294,208,927)  
Net cash provided by operating activities 591,486,340 90,649,247 1,410,642,923 614,545,806  
Cash flows from investing activities:          
Net cash used in investing activities (4,918,689,701) (753,822,176) (6,025,288,715) (3,934,825,126)  
Cash flows from financing activities:          
Proceeds from exercise of share options 114,758,281 17,587,476 38,245,122 44,275,858  
Repurchase of convertible senior notes     (68,632)    
Issuance cost paid for issuance of convertible senior notes     (18,646,101)    
Net cash used in financing activities 6,297,278,555 965,100,162 7,381,818,013 3,972,608,274  
Effect of foreign exchange rate changes on cash and cash equivalents (169,261,838) (25,940,512) 24,758,635 68,323,815  
Net increase/(decrease) in cash and cash equivalents 1,800,813,356 275,986,721 2,791,930,856 720,652,769  
Cash, cash equivalents, and restricted cash, beginning of the year 6,273,958,429 961,526,196 3,482,027,573 2,761,374,804  
Cash, cash equivalents, and restricted cash, end of the year (Note 2(d)) 8,074,771,785 1,237,512,917 6,273,958,429 3,482,027,573  
Supplemental disclosure of non-cash investing and financing cash flow information          
Proceeds from exercise of share options received in subsequent period 9,142,819 1,401,198 40,338,943    
Receivables related to At-The-Market offering 641,065,394       $ 98,247,570
Reportable Legal Entities [Member] | Parent Company [Member]          
Cash flows from operating activities:          
Net income 230,384,653 35,307,993 898,662,226 406,478,694  
Adjustments to reconcile net income to net cash provided by (used in) operating activities:          
Issuance cost paid for issuance of convertible senior notes     18,646,101    
Share of income from subsidiaries (1,015,006,438) (155,556,542) (911,593,940) (348,543,952)  
Guarantee income (5,063,775) (776,057) (8,922,475) (6,249,651)  
Exchange (gain)/loss 73,717,931 11,297,767 (17,153,258) (53,953,395)  
Changes in operating assets and liabilities:          
(Increase)/decrease in due from subsidiaries 592,424,888 90,793,086 (871,067,726) (1,895,298,545)  
(Increase)/decrease in other current assets (9,437,209) (1,446,316) (110,110) 200,153  
Increase/(decrease) in due to subsidiaries (658,106,245) (100,859,194) (14,890,886) 1,177,359,405  
Increase/(decrease) in other current liabilities 9,772,273 1,497,666 1,096,958 (166,056)  
Net cash provided by operating activities (55,522,399) (8,509,180) (876,075,652) (720,173,347)  
Cash flows from investing activities:          
Cash paid for call option     (216,905,850)    
Net cash used in investing activities     (216,905,850)    
Cash flows from financing activities:          
Proceeds from exercise of share options 114,758,281 17,587,476 38,245,122 44,278,857  
Repurchase of convertible senior notes     (68,632)    
Proceeds from issuance of convertible senior notes     585,301,500    
Proceeds from issuance of ordinary shares     488,950,795 663,232,926  
Repurchase of shares (29,294,325) (4,489,552)      
Issuance cost paid for issuance of convertible senior notes     (18,646,101)    
Net cash used in financing activities 85,463,956 13,097,924 1,093,782,684 707,511,783  
Effect of foreign exchange rate changes on cash and cash equivalents (14,991,165) (2,297,496) 245,789 464,662  
Net increase/(decrease) in cash and cash equivalents 14,950,392 2,291,248 1,046,971 (12,196,902)  
Cash, cash equivalents, and restricted cash, beginning of the year 4,556,832 698,365 3,509,861 15,706,763  
Cash, cash equivalents, and restricted cash, end of the year (Note 2(d)) 19,507,224 2,989,613 4,556,832 ¥ 3,509,861  
Supplemental disclosure of non-cash investing and financing cash flow information          
Proceeds from exercise of share options received in subsequent period 9,142,819 1,401,198 40,338,943    
Receivables related to At-The-Market offering 641,065,394       $ 98,247,570
Reportable Legal Entities [Member] | Parent Company [Member] | Call Options [Member]          
Adjustments to reconcile net income to net cash provided by (used in) operating activities:          
Change in fair value (476,290,547) (72,994,720) (84,891,634)    
Reportable Legal Entities [Member] | Parent Company [Member] | 2016 Notes [Member]          
Adjustments to reconcile net income to net cash provided by (used in) operating activities:          
Issuance cost paid for issuance of convertible senior notes     18,646,101    
Change in fair value ¥ 1,202,082,070 $ 184,227,137 ¥ 114,149,092